Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marcocci

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Thyroid : Official Journal of the American Thyroid Association|June 1, 1996
Radioiodine therapy and Graves' ophthalmopathyL Bartalena, C Marcocci
Journal of Endocrinological Investigation|January 15, 2014
Role of oxidative stress and selenium in Graves' hyperthyroidism and orbitopathyC Marcocci, L Bartalena
Journal of Endocrinological Investigation|November 23, 2011
Update on the use of cinacalcet in the management of primary hyperparathyroidismC Marcocci, F Cetani
Frontiers of Hormone Research|March 15, 2002
Fluoride and anabolic steroids in the treatment of glucocorticoid-induced osteoporosisC Marcocci, M Bevilacqua
Journal of Endocrinological Investigation|January 15, 2014
Selenium in endocrinology. ForewordJ Köhrle, C Marcocci
Endocrinology|October 1, 1988
Sodium/proton exchange in the maintenance of intracellular pH in FRTL-5 thyroid cellsC Marcocci, E F Grollman
Endocrine Reviews|April 27, 2000
Management of Graves' ophthalmopathy: reality and perspectivesL Bartalena, A Pinchera, C Marcocci
The Journal of Clinical Endocrinology and Metabolism|February 1, 1996
Cytokine antagonists: new ideas for the management of Graves' ophthalmopathyL Bartalena, C Marcocci, A Pinchera
Journal of Endocrinological Investigation|October 10, 1998
Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy?C Marcocci, L Bartalena, A Pinchera
Journal of Endocrinological Investigation|May 8, 2021
Graves' disease and Graves' orbitopathy following COVID-19G Lanzolla, C Marcocci, M Marinò
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Thyroid : Official Journal of the American Thyroid Association|June 1, 1996
Radioiodine therapy and Graves' ophthalmopathyL Bartalena, C Marcocci
Journal of Endocrinological Investigation|January 15, 2014
Role of oxidative stress and selenium in Graves' hyperthyroidism and orbitopathyC Marcocci, L Bartalena
Journal of Endocrinological Investigation|November 23, 2011
Update on the use of cinacalcet in the management of primary hyperparathyroidismC Marcocci, F Cetani
Frontiers of Hormone Research|March 15, 2002
Fluoride and anabolic steroids in the treatment of glucocorticoid-induced osteoporosisC Marcocci, M Bevilacqua
Journal of Endocrinological Investigation|January 15, 2014
Selenium in endocrinology. ForewordJ Köhrle, C Marcocci
Endocrinology|October 1, 1988
Sodium/proton exchange in the maintenance of intracellular pH in FRTL-5 thyroid cellsC Marcocci, E F Grollman
Endocrine Reviews|April 27, 2000
Management of Graves' ophthalmopathy: reality and perspectivesL Bartalena, A Pinchera, C Marcocci
The Journal of Clinical Endocrinology and Metabolism|February 1, 1996
Cytokine antagonists: new ideas for the management of Graves' ophthalmopathyL Bartalena, C Marcocci, A Pinchera
Journal of Endocrinological Investigation|October 10, 1998
Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy?C Marcocci, L Bartalena, A Pinchera
Journal of Endocrinological Investigation|May 8, 2021
Graves' disease and Graves' orbitopathy following COVID-19G Lanzolla, C Marcocci, M Marinò
Pageof 20